Clinical Trials Browser

Ovarian Neoplasms × Esketamine × 90 days × Clear all

NCT06624878 2026-02-27

Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer

Phase NA Completed

Depression, Ovarian Neoplasms